Literature DB >> 33757632

Epidemiology of abdominal aortic aneurysms.

Christina L Marcaccio1, Marc L Schermerhorn2.   

Abstract

Abdominal aortic aneurysm (AAA) disease remains a major source of morbidity in developed countries and can progress to life-threatening rupture if left untreated, with exceedingly high mortality. The goal of AAA management is to identify and electively repair AAAs before rupture. AAA disease burden and outcomes have improved over time with declining tobacco use and advancements in care across patients' disease course. The introduction of endovascular AAA repair, in particular, has allowed for elective AAA repair in patients previously considered too high risk for open surgery and has contributed to lower rates of AAA rupture over time. However, these improved outcomes are not universally experienced, and disparities continue to exist in the detection, treatment, and outcomes of AAA by sex, race, and ethnicity. Mitigating these disparities requires enhanced, focused efforts at preventing disease, promoting health, and delivering appropriate care among an increasingly diverse patient population.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33757632     DOI: 10.1053/j.semvascsurg.2021.02.004

Source DB:  PubMed          Journal:  Semin Vasc Surg        ISSN: 0895-7967            Impact factor:   1.000


  3 in total

1.  Association between neighborhood deprivation and presenting with a ruptured abdominal aortic aneurysm before screening age.

Authors:  Amanda R Phillips; Elizabeth A Andraska; Katherine M Reitz; Salim Habib; Deirdre Martinez-Meehan; Yancheng Dai; Amber E Johnson; Nathan L Liang
Journal:  J Vasc Surg       Date:  2022-03-18       Impact factor: 4.860

2.  Kunming mouse strain is less susceptible to elastase-induced abdominal aortic aneurysms.

Authors:  Haole Liu; Kangli Tian; Congcong Xia; Panpan Wei; Boyu Xu; Weilai Fu; Yankui Li; Yafeng Li; Liang Bai; Rong Wang; Weirong Wang; Baohui Xu; Enqi Liu; Sihai Zhao
Journal:  Animal Model Exp Med       Date:  2021-12-07

3.  Dapagliflozin Ameliorates the Formation and Progression of Experimental Abdominal Aortic Aneurysms by Reducing Aortic Inflammation in Mice.

Authors:  Haole Liu; Panpan Wei; Weilai Fu; Congcong Xia; Yankui Li; Kangli Tian; Yafeng Li; Daxin Cheng; Jiaying Sun; Yangwei Xu; Ming Lu; Boyu Xu; Yali Zhang; Rong Wang; Weirong Wang; Baohui Xu; Enqi Liu; Sihai Zhao
Journal:  Oxid Med Cell Longev       Date:  2022-01-28       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.